{"disease":{"id":"cholinergic-urticaria","name":"cholinergic urticaria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06201780","title":"Assessment of Serum Levels of Janus Kinase 1 and 2 in Patients With Cholinergic Urticaria","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06948188","title":"Identification of Subpopulations of Patients With Cholinergic Urticaria Based on Infrared Exposure Test Results.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03749148","title":"Cholinergic Urticaria - Efficacy of Dupilumab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT04548869","title":"A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Celldex Therapeutics","has_results":false},{"nct_id":"NCT04853992","title":"Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"JW Pharmaceutical","has_results":true},{"nct_id":"NCT04513548","title":"Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}